CPL @1109 (55.9%) on 12-jun-2018 [ "grant support from _" "It is manufactured by _" "prescription drug manufactured by _" "sales specialist with _" "AB-rated generic equivalent of _" "FDA asked _" "educational grant provided by _" "speakers bureau for _" "drug developed by _" "spray is made by _" "grant/research support from _" "multinational corporations such as _" "you purchase is manufactured by _" "pharmaceutical companies , including _" "unrestricted grant from _" "_ distributes this drug" "new drug from _" "drug manufactured by _" "drug is manufactured by _" "drug , made by _" "drug made by _" "medication is manufactured by _" "Drug Administration asked _" "honoraria from _" "assistance program provided by _" "Administration asked _" "XR is manufactured by _" "educational grant from _" "patent is held by _" "unrestricted educational grant from _" "medication manufactured by _" "drug development at _" "Ritalin , made by _" "immunology research at _" "patient assistance program provided by _" "pharmaceutical sales representative with _" "unrestricted research grant from _" "other healthcare provider to _" "It is marketed by _" "pharmaceutical companies including _" "_ received U.S. Food" "pharmaceutical companies , such as _" "medication is made by _" "research support from _" "major pharmaceutical companies including _" "study was sponsored by _" "lecture fees from _" "consultant fees from _" "independent educational grant from _" "educational grants from _" "Drug companies like _" "medication you purchase is manufactured by _" ] using novartis_pharmaceuticals
CMC @839 (99.9%) on 19-may-2014 [ SUFFIX=icals 1.40507 SUFFIX=cals 1.39467 PREFIX=pha 1.30194 LASTSUFFIX=cals 1.26053 LASTSUFFIX=icals 1.24332 LAST_WORD=pharmaceuticals 1.19492 LASTSUFFIX=als 1.15540 SHORT_WORDSHAPE=a -2.01147 CHARS -2.39324 WORDS -2.63202 ] using novartis_pharmaceuticals
SEAL @206 (50.0%) on 12-feb-2011 [ 1 ] using novartis_pharmaceutical
SEAL @215 (96.9%) on 26-feb-2011 [ 12345 ] using novartis_pharmaceuticals
CPL @1113 (52.5%) on 02-aug-2018 [ "research support from _" "independent educational grant from _" "medication is made by _" "educational grants from _" "DEA has investigated _" "educational grant by _" "former female employees of _" "it is marketed by _" "business unit of _" "study was sponsored by _" "speakers bureau of _" "grant/research support from _" "unrestricted educational grant from _" "biotechnology companies such as _" "drug made by _" "Administration asked _" "unrestricted grant from _" "drug developed by _" "collaboration agreement with _" "_ has received an approvable letter" "It is manufactured by _" "grants/research support from _" "_ received an approvable letter" "_ has marketing rights" "educational grant provided by _" "Development group at _" "educational grant from _" "_ 's Patient Assistance Program" "honorarium from _" "Drug Administration asked _" ] using novartis_pharmaceuticals_corporation
MBL @1116 (99.2%) on 12-sep-2018 [ Promotion of biotechcompany:novartis_pharmaceutical headquarteredin city:east_hanover ] using concept:biotechcompany:novartis_pharmaceutical
CPL @1095 (87.5%) on 17-jan-2018 [ "arg1 Corp in arg2" "arg1 Corporation in arg2" "arg1 Corporation of arg2" ] using (novartis_pharmaceutical, east_hanover)
CPL @1095 (93.8%) on 17-jan-2018 [ "arg1 Corporation based in arg2" "arg1 Corporation in arg2" "arg1 Corporation of arg2" "arg1 Corp in arg2" ] using (novartis_pharmaceuticals, east_hanover)
NELL has only weak evidence for items listed in grey
CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 is marketed by arg2" "arg1 is currently marketed by arg2" ] using (famvir, novartis_pharmaceuticals_corporation)